San Carlos, CA, United States of America

Mary B Sliwkowski



Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 121(Granted Patents)


Company Filing History:


Years Active: 1993-2005

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Mary B Sliwkowski

Introduction

Mary B Sliwkowski, a prominent inventor based in San Carlos, California, has made significant contributions to the field of biotechnology through her innovative patents. With a total of 10 patents to her name, Sliwkowski's work focuses on advancements that can improve patient care and therapeutic applications.

Latest Patents

Among her latest patents, one noteworthy invention is the development of purified forms of DNase. This invention details the identification and characterization of two components of a recombinant preparation of DNase, namely the purified deamidated and non-deamidated human DNases. The separation of these components and the application of the non-deamidated species as a pharmaceutical is particularly significant, especially for patients experiencing pulmonary distress.

Another important patent involves the creation of a recombinant cell line with a constitutive sialidase whose functional expression is disrupted. This invention highlights the purification of sialidase from cell culture fluid derived from Chinese hamster ovary cells and describes how nucleic acid encoding sialidase can be obtained using an oligonucleotide probe designed from amino acid sequence data.

Career Highlights

Mary currently works at Genentech, Inc., a leading biotechnology company known for its innovative approaches in drug development. Throughout her career, Sliwkowski has established herself as a key player in the advancement of therapeutic techniques in the biotechnology sector, showcasing her dedication to improving healthcare outcomes.

Collaborations

In her journey, Mary B Sliwkowski has collaborated with esteemed colleagues such as John Frenz and Edward T. Cox. Together, they have engaged in groundbreaking research that has resulted in significant technological advancements in their field.

Conclusion

Mary B Sliwkowski is an exemplary figure in the world of biotechnology and innovation. Her contributions through patent developments reflect her commitment to enhancing patient care and fostering advancements in medical technology. As she continues her work at Genentech, her impact on the industry remains profound.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…